Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1195699 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL121803 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL29080417 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL10437125 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL4157260 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL28473192 | 1.00 | DNM1 (0.53) | DNM1CA12CA1CA2CA3 | |
| Hydrochloric Acid SCHEMBL11124074 | 0.97 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL1275650 | 0.97 | — | — | |
| Boric Acid SCHEMBL8961512 | 0.89 | DNM1 (0.42) | DNM1CA12CA1CA2CA3 | |
| Putrescine SCHEMBL8585748 | 0.87 | DNM1 (0.65) | DNM1CA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050249663-A1 | Coadministration of transport protein with conjugated cobalamin to deliver agents | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-11-10 | — | — | US | disclosed |
| US-5948878-A | Cationic polymers for nucleic acid transfection and bioactive agent delivery | AVANTI POLAR LIPIDS, INC | 1999-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249663-A1 | Coadministration of transport protein with conjugated cobalamin to deliver agents | SLC19A1, SLC19A2, SLC46A1 | DNM1 4046/4885CA12 2903/4885CA1 4531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.